The Effect of Stabilisation Agents on the Immunomodulatory Properties of Gold Nanoparticles Obtained by Ultrasonic Spray Pyrolysis

Abstract

Gold nanoparticles (GNPs) have been investigated extensively as drug carriers in tumour immunotherapy in combination with photothermal therapy. For this purpose, GNPs should be stabilised in biological fluids. The goal of this study was to examine how stabilisation agents influence cytotoxicity and immune response in vitro. Spherical GNPs, 20 nm in size, were prepared by ultrasonic spray pyrolysis (USP). Three types of stabilising agents were used: sodium citrate (SC), polyvinyl-pyrrolidone (PVP), and poly-ethylene glycol (PEG). Pristine, non-stabilised GNPs were used as a control. The culture models were mouse L929 cells, B16F10 melanoma cells and human peripheral blood mononuclear cells (PBMNCs), obtained from healthy donors. Control SC- and PEG-GNPs were non-cytotoxic at concentrations (range 1–100 µg/mL), in contrast to PVP-GNPs, which were cytotoxic at higher concentrations. Control GNPs inhibited the production of IFN-ϒ slightly, and augmented the production of IL-10 by PHA-stimulated PBMNC cultures. PEG-GNPs inhibited the production of pro-inflammatory cytokines (IL-1, IL-6, IL-8, TNF-α) and Th1-related cytokines (IFN-ϒ and IL-12p70), and increased the production of Th2 cytokines (IL-4 and IL-5). SC-PEG inhibited the production of IL-8 and IL-17A. In contrast, PVP-GNPs stimulated the production of pro-inflammatory cytokines, Th1 cytokines, and IL-17A, but also IL-10. When uptake of GNPs by monocytes/macrophages in PBMNC cultures was analysed, the ingestion of PEG- GNPs was significantly lower compared to SC- and PVP-GNPs. In conclusion, stabilisation agents modulate biocompatibility and immune response significantly, so their adequate choice for preparation of GNPs is an important factor when considering the use of GNPs for application in vivo.

Laser‐induced optothermal response of gold nanoparticles: From a physical viewpoint to cancer treatment application

“…Stabilizing agents are used to maintain the stability of NPs under harsh conditions like in the cell or in the bloodstream. They also prevent aggregation of NPs, improve their stability in water solutions, and change their bioavailability in biological systems [140, 141]. Furthermore, the NPs’ coating impacts structural stability and prevents quenching [142].…”

Antibacterial and Immunomodulatory Potentials of Biosynthesized Ag, Au, Ag-Au Bimetallic Alloy Nanoparticles Using the Asparagus racemosus Root Extract

“…The release of lytic enzyme or oxidative stress can also cause the irreversible damage to the inflamed tissues [79]. The elevation in levels of IL-1β is responsible for various inflammatory disorders such as psoriasis and rheumatoid arthritis [80]. However, the decrease in TNF-α levels is considered a key therapy for rheumatoid arthritis [81].…”

Biocompatible Iron–Boron Nanoparticles Designed for Neutron Capture Therapy Guided by Magnetic Resonance Imaging

“…[ 74,75 ] Other reports also evidenced that B‐containing NPs are non‐cytotoxic up to very high concentrations (40 mg mL −1 ). [ 76 ] The presence of stabilization agents significantly influences the cytotoxicity of NPs, [ 77 ] including Fe oxide NPs, [ 75 ] but the amount of organic stabilizers in the Fe–B NPs is such to avoid negative effects on cell viability. [ 77 ]…”